Low-Dose oxygen enhances macrophage-derived bacterial clearance following cigarette smoke exposure

Journal of Immunology Research

Volumn 2016, Issue , 2016, Pages

  Bain, William G ^a,b   Tripathi, Ashutosh ^a   Mandke, Pooja ^a   Gans, Jonathan H ^a   D'Alessio, Franco R ^a   Sidhaye, Venkataramana K ^a   Aggarwal, Neil R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; CIGARETTE SMOKE; DECTIN 1; INTERLEUKIN 6; OXYGEN; SCAVENGER RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; SMOKE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLONY FORMING UNIT; COMPREHENSION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE EXACERBATION; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MACROPHAGE CULTURE; MOUSE; NONHUMAN; OXYGEN THERAPY; PHAGOCYTOSIS; PNEUMONIA; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; WILD TYPE; ADVERSE EFFECTS; ANIMAL; BACTERIUM; DRUG EFFECTS; IMMUNOLOGY; IMMUNOPHENOTYPING; MACROPHAGE; METABOLISM; MICROBIOLOGY; SMOKE; SMOKING;

ANIMALS; BACTERIA; CYTOKINES; IMMUNOPHENOTYPING; INFLAMMATION MEDIATORS; MACROPHAGES; MACROPHAGES, ALVEOLAR; MICE; OXYGEN; PHAGOCYTOSIS; SMOKE; SMOKING;

EID: 84976629853     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2016/1280347     Document Type: Article

References (44)

1. Nocturnal Oxygen Therapy Trial Group, "Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial," Annals of Internal Medicine, vol. 93, no. 3, pp. 391-398, 1980.
2. "Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema," The Lancet, vol. 317, no. 8222, pp. 681-686, 1981.
3. M. A. Austin, K. E. Wills, L. Blizzard, E. H. Walters, and R. Wood-Baker, "Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial," The British Medical Journal, vol. 341, Article IDc5462, 2010.
4. A. D. Cornet, A. J. Kooter, M. J. L. Peters, and Y. M. Smulders, "The potential harmof oxygen therapy inmedical emergencies," Critical Care, vol. 17, no. 2, article 313, 2013.
5. C. E. O. Baleeiro, S. E. Wilcoxen, S. B. Morris, T. J. Standiford, and R. Paine III, "Sublethal hyperoxia impairs pulmonary innate immunity," The Journal of Immunology, vol. 171, no. 2, pp. 955-963, 2003.
6. N. R. Aggarwal, F. R. DAlessio, K. Tsushima et al., "Moderate oxygen augments lipopolysaccharide-induced lung injury in mice," American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 298, no. 3, pp. L371-L381, 2010.
7. T. Hussell and T. J. Bell, "Alveolar macrophages: plasticity in a tissue-specific context," Nature Reviews Immunology, vol. 14, no. 2, pp. 81-93, 2014.
8. R. J. Snelgrove, J. Goulding, A. M. Didierlaurent et al., "A critical function for CD200 in lung immune homeostasis and the severity of influenza infection," Nature Immunology, vol. 9, no. 9, pp. 1074-1083, 2008.
9. K. Sun and D. W. Metzger, "Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection," Nature Medicine, vol. 14, no. 5, pp. 558-564, 2008.
10. V. M. Keatings, P. D. Collins, D. M. Scott, and P. J. Barnes, "Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma,"AmericanJournal of Respiratory and Critical Care Medicine, vol. 153, no. 2, pp. 530-534, 1996.
11. A. Pesci, B. Balbi, M. Majori et al., "Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease," European Respiratory Journal, vol. 12, no. 2, pp. 380-386, 1998.
12. A. Di Stefano, A. Capelli, M. Lusuardi et al., "Severity of airflow limitation is associated with severity of airway inflammation in smokers," American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 4, pp. 1277-1285, 1998.
13. R. Shaykhiev, A. Krause, J. Salit et al., "Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease," Journal of Immunology, vol. 183, no. 4, pp. 2867-2883, 2009.
14. N. R. Aggarwal, F. R. DAlessio, Y. Eto et al., "Macrophage A2A adenosinergic receptor modulates oxygen-induced augmentation ofmurine lung injury," American Journal of Respiratory Cell and Molecular Biology, vol. 48, no. 5, pp. 635-645, 2013.
15. N. R. Aggarwal, E. Chau, B. T. Garibaldi et al., "Aquaporin 5 regulates cigarette smoke induced emphysema by modulating barrier and immune properties of the epithelium," Tissue Barriers, vol. 1, no. 4, Article ID e25248, 2013.
16. F. R. DAlessio, K. Tsushima, N. R. Aggarwal et al., "CD4+ CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury," The Journal of Clinical Investigation, vol. 119, no. 10, pp. 2898-2913, 2009.
17. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, "Protein measurement with the Folin phenol reagent," The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265-275, 1951.
18. A. G. Drannik, M. A. Pouladi, C. S. Robbins, S. I. Goncharova, S. Kianpour, and M. R. Stämpfli, "Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection," American Journal of Respiratory and Critical Care Medicine, vol. 170, no. 11, pp. 1164-1171, 2004.
19. J. P. Edwards, X. Zhang, K. A. Frauwirth, and D. M. Mosser, "Biochemical and functional characterization of three activated macrophage populations," Journal of Leukocyte Biology, vol. 80, no. 6, pp. 1298-1307, 2006.
20. S. Bozinovski, R. Vlahos, Y. Zhang et al., "Carbonylation caused by cigarette smoke extract is associated with defective macrophage immunity," American Journal of Respiratory Cell and Molecular Biology, vol. 45, no. 2, pp. 229-236, 2011.
21. D. Worlitzsch, R. Tarran, M. Ulrich et al., "Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients," The Journal of Clinical Investigation, vol. 109, no. 3, pp. 317-325, 2002.
22. T. F. Murphy, A. L. Brauer, K. Eschberger et al., "Pseudomonas aeruginosa in chronic obstructive pulmonary disease," American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 8, pp. 853-860, 2008.
23. S. Sethi and T. F. Murphy, "Infection in the pathogenesis and course of chronic obstructive pulmonary disease," The New England Journal of Medicine, vol. 359, no. 22, pp. 2312-2365, 2008.
24. D. R. Knighton, V. D. Fiegel, T. Halverson, S. Schneider, T. Brown, and C. L. Wells, "Oxygen as an antibiotic. The effect of inspired oxygen on bacterial clearance," Archives of Surgery, vol. 125, no. 1, pp. 97-100, 1990.
25. G. D. Brown, J. Herre, D. L. Williams, J. A. Willment, A. S. J. Marshall, and S. Gordon, "Dectin-1 mediates the biological effects of β-glucans,"The Journal of ExperimentalMedicine, vol. 197, no. 9, pp. 1119-1124, 2003.
26. P. R. Taylor, S. V. Tsoni, J. A. Willment et al., "Dectin-1 is required for β-glucan recognition and control of fungal infection," Nature Immunology, vol. 8, no. 1, pp. 31-38, 2007.
27. C. H. Serezani, S. Kane, L. Collins, M. Morato-Marques, J. J. Osterholzer, and M. Peters-Golden, "Macrophage dectin-1 expression is controlled by leukotriene B4 via a GM-CSF/PU. 1 axis," The Journal of Immunology, vol. 189, no. 2, pp. 906-915, 2012.
28. D. E. Griffith, J. G. N. Garcia, H. L. James, K. S. Callahan, S. Iriana, and D. Holiday, "Hyperoxic exposure in humans. Effects of 50 percent oxygen on alveolar macrophage leukotriene B4 synthesis," Chest, vol. 101, no. 2, pp. 392-397, 1992.
29. B. Ferwerda, G. Ferwerda, T. S. Plantinga et al., "Human dectin-1 deficiency and mucocutaneous fungal infections," The New England Journal ofMedicine, vol. 361, no. 18, pp. 1760-1767, 2009.
30. T. S. Plantinga, W. J. F. M. van der Velden, B. Ferwerda et al., "Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients," Clinical Infectious Diseases, vol. 49, no. 5, pp. 724-732, 2009.
31. M. A. S. H. Mennink-Kersten, D. Ruegebrink, and P. E. Verweij, "Pseudomonas aeruginosa as a cause of 1, 3-β-D-glucan assay reactivity," Clinical Infectious Diseases, vol. 46, no. 12, pp. 1930-1931, 2008.
32. Y. Lequette, E. Rollet, A. Delangle, E. P. Greenberg, and J.-P. Bohin, "Linear osmoregulated periplasmic glucans are encoded by the opgGH locus of Pseudomonas aeruginosa," Microbiology, vol. 153, no. 10, pp. 3255-3263, 2007.
33. K. A. Heyl, T. E. Klassert, A. Heinrich et al., "Dectin-1 is expressed in human lung and mediates the proinflammatory immune response to nontypeable Haemophilus influenzae," mBio, vol. 5, no. 5, Article ID e01492-14, 2014.
34. I. L. Ahrén, D. L. Williams, P. J. Rice, A. Forsgren, and K. Riesbeck, "The importance of a β-glucan receptor in the nonopsonic entry of nontypeable Haemophilus influenzae into human monocytic and epithelial cells," The Journal of Infectious Diseases, vol. 184, no. 2, pp. 150-158, 2001.
35. K. Sun and D. W. Metzger, "Influenza infection suppresses NADPH oxidase-dependent phagocytic bacterial clearance and enhances susceptibility to secondary methicillin-resistant Staphylococcus aureus infection," The Journal of Immunology, vol. 192, no. 7, pp. 3301-3307, 2014.
36. M. L. Manni, L. P. Tomai, C. A. Norris et al., "Extracellular superoxide dismutase in macrophages augments bacterial killing by promoting phagocytosis," American Journal of Pathology, vol. 178, no. 6, pp. 2752-2759, 2011.
37. L. M. Carlsson, J. Jonsson, T. Edlund, and S. L. Marklund, "Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia," Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 14, pp. 6264-6268, 1995.
38. M. Jaguin, O. Fardel, and V. Lecureur, "Exposure to diesel exhaust particle extracts (DEPe) impairs some polarization markers and functions of human macrophages through activation of AhR and Nrf2," PLoS ONE, vol. 10, no. 2, Article ID e0116560, 2015.
39. A. Nolan, M. Weiden, A. Kelly et al., "CD40 and CD80/86 act synergistically to regulate inflammation and mortality in polymicrobial sepsis," American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 3, pp. 301-308, 2008.
40. X. Li, A. Utomo, X. Cullere et al., "The β-glucan receptor dectin-1 activates the integrin Mac-1 in neutrophils via vav protein signaling to promote Candida albicans clearance," Cell Host and Microbe, vol. 10, no. 6, pp. 603-615, 2011.
41. J. C. Phipps, D. M. Aronoff, J. L. Curtis, D. Goel, E. OBrien, and P. Mancuso, "Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complementmediated phagocytosis of Streptococcus pneumoniae," Infection and Immunity, vol. 78, no. 3, pp. 1214-1220, 2010.
42. I. Ni, C. Ji, and N. Vij, "Second-hand cigarette smoke impairs bacterial phagocytosis in macrophages by modulating CFTR dependent lipid-rafts," PLoS ONE, vol. 10, no. 3, Article ID e0121200, 2015.
43. F. V. Loures, E. F. Araújo, C. Feriotti, S. B. Bazan, and V. L. G. Calich, "TLR-4 cooperates withDectin-1 and mannose receptor to expand Th17 and Tc17 cells induced by Paracoccidioides brasiliensis stimulated dendritic cells," Frontiers inMicrobiology, vol. 6, article 261, 2015.
44. S. Hodge, G. Hodge, H. Jersmann et al., "Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease," American Journal of Respiratory and Critical CareMedicine, vol. 178, no. 2, pp. 139-148, 2008.